10 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
the consistent availability of raw materials and distribution.
IND-Enabling Research. Prior to IND submission, we must conduct comprehensive IND … of the agreement even if the manufacturers do not deliver adequate supply of the product candidates or their components.
Raw materials and components
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
could be materially adversely affected. Some of our suppliers have experienced delays in securing critical raw materials; while this has not materially
424B1
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus with pricing info
12:59pm
adversely affected. Some of our suppliers have experienced delays in securing critical raw materials; while this has not materially impacted their services
S-1
snmi8njubrn d322cu
29 Jun 23
IPO registration
4:39pm
DRS/A
6v65aalhy8ksxsi
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
hel7k
2 May 23
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next